Published in J Pharmacol Exp Ther on May 30, 2007
Scavenger receptors in homeostasis and immunity. Nat Rev Immunol (2013) 1.77
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol (2009) 1.17
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther (2011) 1.12
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci (2012) 1.04
Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood (2013) 1.00
NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model. Microvasc Res (2009) 0.89
Platelet hyperreactivity, scavenger receptors and atherothrombosis. J Thromb Haemost (2009) 0.84
Extracellular diffusion and permeability effects on NO-RBCs interactions using an experimental and theoretical model. Microvasc Res (2009) 0.83
Aspirin resistance: Fact or fiction? A point of view. World J Cardiol (2010) 0.76
The Use of Statins and Risk of Community-Acquired Pneumonia. Curr Infect Dis Rep (2017) 0.75
Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep (2017) 0.75
Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J (2012) 3.15
Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res (2007) 2.87
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide. J Hypertens (2010) 2.68
Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity (2002) 2.47
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res (2005) 2.30
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res (2003) 2.08
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther (2015) 2.00
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol (2003) 1.91
Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res (2009) 1.83
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther (2002) 1.74
Dietary recommendations in the prevention and treatment of coronary heart disease: do we have the ideal diet yet? Am J Cardiol (2004) 1.74
LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem (2010) 1.65
Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension (2008) 1.58
A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function. J Hypertens (2009) 1.58
Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol (2011) 1.58
Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol (2006) 1.56
Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol (2006) 1.54
LOX-1 mediates vascular lipid retention under hypertensive state. J Hypertens (2010) 1.49
Assessment of left ventricular function: comparison of cardiac multidetector-row computed tomography with two-dimension standard echocardiography for assessment of left ventricular function. Int J Cardiovasc Imaging (2007) 1.49
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation. Cardiovasc Drugs Ther (2013) 1.48
Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology (2013) 1.46
Lectin-like oxidized LDL receptor 1 is involved in CRP-mediated complement activation. Clin Chem (2011) 1.46
Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid. J Cardiovasc Med (Hagerstown) (2012) 1.42
Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes. Cardiovasc Res (2003) 1.41
LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation (2003) 1.40
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension (2004) 1.38
High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand? Eur Heart J (2007) 1.38
Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res (2004) 1.35
Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol (2004) 1.35
Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett (2005) 1.34
Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation (2008) 1.34
Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther (2011) 1.33
Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell (2013) 1.30
Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A (2003) 1.29
Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol (2004) 1.28
Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res (2005) 1.27
Assessing the credibility of the "YouTube approach" to health information on acute myocardial infarction. Clin Cardiol (2012) 1.26
Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol (2007) 1.24
C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res (2004) 1.23
Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4-hydroxynonenal. Aging Cell (2005) 1.23
Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res (2005) 1.22
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res (2005) 1.20
Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun (2004) 1.20
Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J (2009) 1.19
Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation. J Hypertens (2005) 1.18
Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep (2013) 1.17
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol (2009) 1.17
Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res (2004) 1.17
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol (2013) 1.15
Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Vascul Pharmacol (2005) 1.15
Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res (2006) 1.14
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis (2005) 1.14
Loss of exercise-induced cardioprotection after cessation of exercise. J Appl Physiol (1985) (2003) 1.12
MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker. J Am Coll Cardiol (2014) 1.12
The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther (2011) 1.12
Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci (2011) 1.12
Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med (2009) 1.12
Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound (2007) 1.12
Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun (2003) 1.11
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther (2002) 1.10
Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis (2005) 1.10
Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma. Int J Cancer (2014) 1.10
A focal domain of extreme demethylation within D4Z4 in FSHD2. Neurology (2013) 1.08
LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.08
Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology (2004) 1.08
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis (2003) 1.07
Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal (2011) 1.07
LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res (2009) 1.07
Exercise training provides cardioprotection against ischemia-reperfusion induced apoptosis in young and old animals. Exp Gerontol (2005) 1.06
Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol (2007) 1.06
Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study. J Atheroscler Thromb (2012) 1.05
Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Diabetol (2013) 1.05
ALDH2 protects against stroke by clearing 4-HNE. Cell Res (2013) 1.05
Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol (2003) 1.05
Common carotid arterial interadventitial distance (diameter) as an indicator of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk in Community Cohort Limited Access Data (ARICLAD), 1987-89. Cardiovasc Ultrasound (2006) 1.05
TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol (2003) 1.05
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci (2012) 1.04
Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res (2005) 1.04
Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina. Arch Ophthalmol (2002) 1.03
Life span and stress resistance of Caenorhabditis elegans are differentially affected by glutathione transferases metabolizing 4-hydroxynon-2-enal. Mech Ageing Dev (2006) 1.03
Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol (2004) 1.03
Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood (2013) 1.00
Psb27, a transiently associated protein, binds to the chlorophyll binding protein CP43 in photosystem II assembly intermediates. Proc Natl Acad Sci U S A (2011) 1.00
LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J (2006) 1.00
LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res (2008) 1.00